This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrag, S. J.
Right arrow Articles by Dowell, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrag, S. J.
Right arrow Articles by Dowell, S. F.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, October 2000, p. 588-601, Vol. 13, No. 4
0893-8512/00/$04.00+0

Limiting the Spread of Resistant Pneumococci: Biological and Epidemiologic Evidence for the Effectiveness of Alternative Interventions

Stephanie J. Schrag,* Bernard Beall, and Scott F. Dowell

Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Streptococcus pneumoniae infections are a leading cause of respiratory illness in young children, the elderly, and persons with chronic medical conditions. The emergence of multidrug-resistant pneumococci has compromised the effectiveness of antibiotic therapy for pneumococcal infections. As antibiotic-resistant strains increase in prevalence, there is a need for interventions that minimize the spread of resistant pneumococci. In this review we provide a framework for understanding the spread of pneumococcal resistance and evaluate proposed interventions to reduce this spread. Pneumococci differ from many drug-resistant pathogens because asymptomatic carriers play a key role in transmission of resistant strains and the genes encoding resistance are spread primarily by transformation and conjugative transposons. Evidence suggests that modifications of treatment regimens that have proved effective at limiting resistance in other pathogens may not prevent the spread of pneumococcal resistance. In contrast, programs encouraging more judicious antibiotic use have been shown to be effective. Additionally, a newly developed conjugate pneumococcal vaccine holds great potential as an "antiresistance vaccine" that simultaneously reduces the burden of invasive disease and the prevalence of resistant strains. Several areas of future epidemiologic and laboratory research hold promise to contribute to the reduced spread of pneumococcal resistance.

* Corresponding author. Mailing address: Respiratory Diseases Branch, MS-C23, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-4646. Fax: (404) 639-3970. E-mail: zha6{at}cdc.gov.

Clinical Microbiology Reviews, October 2000, p. 588-601, Vol. 13, No. 4
0893-8512/00/$04.00+0


This article has been cited by other articles:

  • Eiland, L. S. (2008). Increasing Prevalence of Pneumococcal Serotype 19A Among US Children. Journal of Pharmacy Practice 21: 356-362 [Abstract]  
  • Sevillano, D., Aguilar, L., Alou, L., Gimenez, M.-J., Echevarria, O., Cafini, F., Valero, E., Fenoll, A., Prieto, J. (2006). Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations. J Antimicrob Chemother 58: 794-801 [Abstract] [Full Text]  
  • Garbutt, J., Rosenbloom, I., Wu, J., Storch, G. A. (2006). Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.. Pediatrics 117: e1087-e1094 [Abstract] [Full Text]  
  • Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., Facklam, R. R., Jorgensen, J. H., Besser, J., Zell, E. R., Schuchat, A., Whitney, C. G., Active Bacterial Core Surveillance of the Emerging, (2006). Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae. NEJM 354: 1455-1463 [Abstract] [Full Text]  
  • Garbutt, J., St. Geme, J. W. III, May, A., Storch, G. A., Shackelford, P. G. (2004). Developing Community-Specific Recommendations for First-Line Treatment of Acute Otitis Media: Is High-Dose Amoxicillin Necessary?. Pediatrics 114: 342-347 [Abstract] [Full Text]  
  • Shutt, C. K., Samore, M., Carroll, K. C. (2004). Comparison of the Denka Seiken Slide Agglutination Method to the Quellung Test for Serogrouping of Streptococcus pneumoniae Isolates. J. Clin. Microbiol. 42: 1274-1276 [Abstract] [Full Text]  
  • Hidalgo, M., Castaneda, E., Arias, C. A. (2003). Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae. J Antimicrob Chemother 52: 300-302 [Abstract] [Full Text]  
  • Odenholt, I., Gustafsson, I., Lowdin, E., Cars, O. (2003). Suboptimal Antibiotic Dosage as a Risk Factor for Selection of Penicillin-Resistant Streptococcus pneumoniae: In Vitro Kinetic Model. Antimicrob. Agents Chemother. 47: 518-523 [Abstract] [Full Text]  
  • Perz, J. F., Craig, A. S., Coffey, C. S., Jorgensen, D. M., Mitchel, E., Hall, S., Schaffner, W., Griffin, M. R. (2002). Changes in Antibiotic Prescribing for Children After a Community-wide Campaign. JAMA 287: 3103-3109 [Abstract] [Full Text]  
  • Baba, H., Kawamura, I., Kohda, C., Nomura, T., Ito, Y., Kimoto, T., Watanabe, I., Ichiyama, S., Mitsuyama, M. (2002). Induction of Gamma Interferon and Nitric Oxide by Truncated Pneumolysin That Lacks Pore-Forming Activity. Infect. Immun. 70: 107-113 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»